Literature DB >> 20214525

Early-stage cervical cancer: is surgery better than radiotherapy?

Manuela Undurraga1, Pierre Loubeyre, Jean-Bernard Dubuisson, Dominique Schneider, Patrick Petignat.   

Abstract

Patients with early-stage cervical cancer may be treated appropriately with either radical surgery or radiation therapy. As most patients will be cured of their disease, side-effects of therapy and quality of life become of great importance. Individualization of treatment to reduce therapy-associated morbidity should be the main goal in cervical cancer management. Recent developments in surgical techniques, such as laparoscopy, nerve-sparing radical hysterectomy, sentinel lymph node biopsy, trachelectomy and 'less radical' hysterectomy, have contributed to reduce the morbidity of the surgical treatment. The use of postoperative radiotherapy or chemoradiation leads to more pronounced side effects than after either surgery or irradiation alone. Therefore, prognostic factors should be used to select patients for either surgery or radiotherapy alone to minimize the increased toxicities associated with the combination. The objectives of this review are to discuss the evidence supporting radical surgery, 'less radical' surgery and radiotherapy with regard to complication rate and quality of life.

Entities:  

Mesh:

Year:  2010        PMID: 20214525     DOI: 10.1586/era.09.192

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  15 in total

1.  Neoadjuvant chemotherapy followed by radical surgery as an alternative treatment to concurrent chemoradiotherapy for young premenopausal patients with FIGO stage IIB squamous cervical carcinoma.

Authors:  ShanShan Yang; Ying Gao; Jing Sun; Bairong Xia; TianBo Liu; HongXia Zhang; Qi Li; Min Xiao; YunYan Zhang
Journal:  Tumour Biol       Date:  2015-01-21

Review 2.  Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence.

Authors:  Shinya Matsuzaki; Maximilian Klar; Mikio Mikami; Muneaki Shimada; Brendan H Grubbs; Keiichi Fujiwara; Lynda D Roman; Koji Matsuo
Journal:  Curr Oncol Rep       Date:  2020-02-12       Impact factor: 5.075

3.  Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.

Authors:  Mika Okazawa-Sakai; Takanori Yokoyama; Etsuko Fujimoto; Shinichi Okame; Yuko Shiroyama; Takashi Yokoyama; Kazuhiro Takehara
Journal:  Int J Clin Oncol       Date:  2018-02-14       Impact factor: 3.402

4.  Postoperative Health-Related Quality of Life of Cervical Cancer Patients - A Comparison between the Wertheim-Meigs Operation and Total Mesometrial Resection (TMMR).

Authors:  E Sowa; S Kuhnt; A Hinz; C Schröder; T Deutsch; K Geue
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-07       Impact factor: 2.915

5.  Radiotherapy for Japanese elderly patients with cervical cancer: preliminary survival outcomes and evaluation of treatment-related toxicity.

Authors:  Kenji Yoshida; Ryohei Sasaki; Hideki Nishimura; Daisuke Miyawaki; Tetsuya Kawabe; Yoshiaki Okamoto; Koji Nakabayashi; Shigeki Yoshida; Kazuro Sugimura
Journal:  Arch Gynecol Obstet       Date:  2010-11-30       Impact factor: 2.344

6.  Clinical features, outcome and risk factors in cervical cancer patients after surgery for chronic radiation enteropathy.

Authors:  Jianbo Yang; Chao Ding; Tenghui Zhang; Liang Zhang; Tengfei Lv; Xiaolong Ge; Jianfeng Gong; Weiming Zhu; Ning Li; Jieshou Li
Journal:  Radiat Oncol       Date:  2015-06-06       Impact factor: 3.481

7.  Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience.

Authors:  Ming-Mo Hou; Xiaochun Liu; Jennifer Wheler; Aung Naing; David Hong; Robert L Coleman; Apostolia Tsimberidou; Filip Janku; Ralph Zinner; Karen Lu; Razelle Kurzrock; Siqing Fu
Journal:  Oncotarget       Date:  2014-11-30

8.  Influence of metal of the applicator on the dose distribution during brachytherapy.

Authors:  Chin-Hui Wu; An-Cheng Shiau; Yi-Jen Liao; Hsin-Yu Lin; Yen-Wan Hsueh Liu; Shih-Ming Hsu
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

9.  Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer.

Authors:  Yanlan Chai; Tao Wang; Juan Wang; Yunyi Yang; Ying Gao; Jiyong Gao; Shangfeng Gao; Yueling Wang; Xi Zhou; Zi Liu
Journal:  BMC Cancer       Date:  2014-02-04       Impact factor: 4.430

10.  Comparison of concurrent chemoradiotherapy followed by radical surgery and high-dose-rate intracavitary brachytherapy: a retrospective study of 240 patients with FIGO stage IIB cervical carcinoma.

Authors:  Ning Wang; Wei-Wei Li; Jian-Ping Li; Juan-Yue Liu; Yong-Chun Zhou; Ying Zhang; Jing Hu; Yan-Hong Huang; Yan Chen; Li-Chun Wei; Mei Shi
Journal:  Onco Targets Ther       Date:  2014-01-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.